跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 214 条关于
“EmpNia”
全部
214
临床试验
186
药物
4
机构
9
资讯
15
去年
EmpNia Receives FDA Clearance for eMotus Respiratory Motion Management System in Radiation Therapy
去年
Emyria Completes $2.25M Capital Raise, Chairman Invests $1M
去年
Amplia Therapeutics Resumes ACCENT Trial Enrollment for Pancreatic Cancer
2年前
Emyria's MDMA-Assisted Therapy Shows Promise in PTSD Interim Trial Results
去年
Amplia Therapeutics' Narmafotinib Shows Promise in Phase 2a Pancreatic Cancer Trial
去年
Emyria Reports Significant MDMA-Assisted Therapy Benefits for PTSD in Clinical Trial
9个月前
Amplia Therapeutics Secures U.S. Patent Protection for FAK Inhibitor Narmafotinib Through 2040
去年
Amplia Therapeutics' Narmafotinib Shows Promise in Pancreatic Cancer Trial, Triggering Expanded Enrollment
去年
Medibank Partners with Emyria to Fund Innovative PTSD Treatment Program in Australian Healthcare First
去年
Long-Acting Injectable Antipsychotics Show Promise in Adolescent Bipolar Mania Management
第 1 页,共 2 页
上一页
下一页